Czech proposals could mean new barriers for industry
This article was originally published in Clinica
Companies marketing medical devices in the Czech Republic could face a dramatic increase in their regulatory workload in October. The Health Ministry has prepared a proposal which, if approved by the government, would force manufacturers to meet both old and new regulatory requirements at the same time.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.